Meletios Dimopoulos

Professor

National and Kapodistrian University of Athens

Greece

Research Interests

Explore related searches

Professors in Cancer Biology

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (17)

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Collaborators (6)

Ioannis Ntanasis-Stathopoulos

National and Kapodistrian University of Athens

GREECE

View details

Evagelos Gikas

PROFESSOR

National and Kapodistrian University of Athens

GREECE

View details

Nikolaos Thomaidis

PROFESSOR

National and Kapodistrian University of Athens

GREECE

View details

Efstathios Kastritis

Professor

National and Kapodistrian University of Athens

GREECE

View details

Evangelos Terpos

Professor of Hematology

National and Kapodistrian University of Athens - Faculty of Medicine

GREECE

View details

Michalis Liontos

National and Kapodistrian University of Athens

GREECE

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Meletios Dimopoulos

Research Interests

Explore related searches

Contact this professor

Articles (17)

Necrotizing Laryngitis in Patients with Hematologic Disease: The First Case-Report Due to PDR <i>Acinetobacter baumannii</i> and Literature Review

The Interplay between the DNA Damage Response (DDR) Network and the Mitogen-Activated Protein Kinase (MAPK) Signaling Pathway in Multiple Myeloma

The Prognostic Role of BRD4 Expression in High-Grade Serous Ovarian Cancer

Unraveling the Role of the NLRP3 Inflammasome in Lymphoma: Implications in Pathogenesis and Therapeutic Strategies

Metabolomics Point out the Effects of Carfilzomib on Aromatic Amino Acid Biosynthesis and Degradation

Real-World Effectiveness and Safety of Belantamab Mafodotin Monotherapy in Triple-Class Refractory Multiple Myeloma

<i>MYD88</i> Wild Type in IgM Monoclonal Gammopathies: From Molecular Mechanisms to Clinical Challenges

Use of Oral Antivirals Ritonavir-Nirmatrelvir and Molnupiravir in Patients with Multiple Myeloma Is Associated with Low Rates of Severe COVID-19: A Single-Center, Prospective Study

Monoclonal Gammopathy of Thrombotic Significance

EPH/Ephrin Signaling in Normal Hematopoiesis and Hematologic Malignancies: Deciphering Their Intricate Role and Unraveling Possible New Therapeutic Targets

Optimal Time Interval between Neoadjuvant Platinum-Based Chemotherapy and Interval Debulking Surgery in High-Grade Serous Ovarian Cancer

Metaplastic Carcinoma of the Breast: Case Series of a Single Institute and Review of the Literature

Tixagevimab/Cilgavimab as Pre-Exposure Prophylaxis against COVID-19 for Multiple Myeloma Patients: A Prospective Study in the Omicron Era

Tenofovir-Induced Fanconi Syndrome Presenting with Life-Threatening Hypokalemia: Review of the Literature and Recommendations for Early Detection

Daratumumab, Bortezomib, and Dexamethasone for Treatment of Patients with Relapsed or Refractory Multiple Myeloma and Severe Renal Impairment: Results from the Phase 2 GMMG-DANTE Trial

Approach to Contemporary Risk Assessment, Prevention and Management of Thrombotic Complications in Multiple Myeloma

The Combination of Panobinostat and Melphalan for the Treatment of Patients with Multiple Myeloma

Collaborators (6)

Ioannis Ntanasis-Stathopoulos

Evagelos Gikas

Nikolaos Thomaidis

Efstathios Kastritis

Evangelos Terpos

Michalis Liontos

Make your next move.